Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FREM2 antisense RNA 1 (FREM2-AS1) is a long non-coding RNA (lncRNA) gene located on human chromosome 13 (reverse strand, GRCh38: 38,821,798-38,827,570)[5]. It is transcribed as an antisense RNA relative to the FREM2 gene and is catalogued under the NCBI Gene accession number 100874073[3]. To date, its precise biological roles, disease relevance, and potential as a therapeutic or diagnostic target remain unexplored, and it is not listed as a canonical therapeutic target in public databases. FREM2-AS1 may have regulatory functions typical of lncRNAs (e.g., modulation of gene expression in cis or trans), but explicit data for this transcript is lacking in the current genetic and biomedical literature[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FREM2 antisense RNA 1 (FREM2-AS1).